<DOC>
	<DOC>NCT02996760</DOC>
	<brief_summary>Women in assisted reproduction treatment they receive own or donated embryos and presenting an endometrial development less than 5 mm despite having received treatment with estrogen therapy knowing the clinical value of using the PRGF-Endoret therapy and endometrial level applications to improve endometrial thickness endometrial preparations for embryo transfer.</brief_summary>
	<brief_title>Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.</brief_title>
	<detailed_description />
	<mesh_term>Mitogens</mesh_term>
	<criteria>Women receiving cycle of oocytes outside or embryos (own / others), in the treatment of substituted cycle type. Less than 5mm despite 10 days with standard doses of estrogen therapy (6mg / 24h) Endometrio History of pelvic inflammatory disease Risk of infection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>